Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.430
-0.040 (-1.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Quipt Home Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Quipt Home Medical stock have an average target of 3.15, with a low estimate of 2.30 and a high estimate of 4.00. The average target predicts an increase of 29.63% from the current stock price of 2.43.
Analyst Consensus: Buy
* Price targets were last updated on Aug 19, 2025.
Analyst Ratings
The average analyst rating for Quipt Home Medical stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.7 → $2.3 | Hold | Maintains | $1.7 → $2.3 | -5.35% | Aug 19, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +64.61% | May 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 → $1.7 | Strong Buy → Hold | Downgrades | $4 → $1.7 | -30.04% | May 13, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +146.91% | Dec 20, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +188.07% | Aug 21, 2024 |
Financial Forecast
Revenue This Year
244.50M
from 245.92M
Decreased by -0.58%
Revenue Next Year
314.65M
from 244.50M
Increased by 28.69%
EPS This Year
-0.20
from -0.16
EPS Next Year
-0.06
from -0.20
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 259.4M | 327.0M | |
| Avg | 244.5M | 314.7M | |
| Low | 232.3M | 299.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.5% | 33.8% | |
| Avg | -0.6% | 28.7% | |
| Low | -5.5% | 22.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | 0.11 | |
| Avg | -0.20 | -0.06 | |
| Low | -0.23 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.